Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An experimental approach to protect HIV-fighting T cells has been cleared for its first human trial.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
CRISPR gene editing eliminates HIV in mice
This amfAR grant hopes to find out. It’s part of $1.16 million in new funding from ARCHE.
A third of mice treated with gene editing technique plus long-acting antiretrovirals showed no remaining traces of HIV.
Interfering with this receptor on immune cells could have harmful health consequences.
Researchers have developed a new gene therapy approach for children with severe combined immunodeficiency.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.
The Avant-Garde Awards promote research in HIV treatment and prevention in drug users.
A slew of media outlets erroneously reported that scientists might be just three years away from developing a cure for HIV.
Cutting through the hype and hyperbole.
Researchers significantly reduced HIV levels in mice with a genetic therapy that induces immune cells to better fight the virus.
Scientists have proved that it is possible to engineer immune cells to control HIV without ongoing antiretroviral therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.